Novel anti-microbial metallic surfaces for infection control
Novel anti-microbial metallic surfaces for infection control
批准号:
2595126
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2021
资助国家:
英国
项目状态:
未结题
起止时间:
2021 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Overview:Worldwide antibiotic use rose by 40% between 2000 and 2010, which combined with international travel and migration has allowed antimicrobial resistant pathogens to spread. There is a global shortage of effective antimicrobial agents, and for some infections there are now no treatments. The UK government's Review on Antimicrobial Resistance (AMR) has estimated that by 2050, 10 million people a year will die from AMR infections. The impact of AMR will not be seen only in terms of morbidity and mortality but also in the economy with an approximation that if no new antimicrobial treatments are found then by 2050 the world economy will have lost 7% of its GDP, $100.2 trillion. Currently every year in Europe 33,000 people die from infections they have caught whilst in hospital. Infectious diseases are a significant health and economic burden in the UK also, accounting for 7% of deaths and annual costs of £30bn. The shortage of effective antimicrobial treatments has been compounded by the lack of novel agents in development and a lack of alternative strategies to reduce microbial spread. New ways of preventing the spread of antibiotic resistant bacteria especially amongst vulnerable populations, such as those in the healthcare system could reduce the number of healthcare associated infections and reduce antibiotic usage. The sponsor company in collaboration with Swansea University will work to identify effective nano reservoir systems, show the effectiveness at reducing or preventing microbial growth on the surface, and prove the technology can create a reduction in antibiotic resistant bacteria on surfaces. The surfaces need to be highly durable and not cause a reaction to humans upon touch, due to the high usage in a hospital environment.The Research Engineer will focus on investigating the properties of the nano reservoir structures and to assess their efficacy against antibiotic resistant bacteria (e.g., Staphylococcus aureus and Escherichia coli) by using antibiotic susceptibility methods. Project Aims:1. Develop novel nano reservoirs that can be combined effectively with a range of anti-microbial agents.2. Determine the most effective coating technique to allow optimal release of antimicrobial agents. 3. To determine whether a range of clinically relevant antibiotic sensitive and antibiotic resistant strains of bacteria are inhibited by novel surfaces/systems.4. To establish which surface/system has the broadest range of activity.5. To ascertain how the duration of exposure impacts on the efficacy of the surface/system under consideration.Predicted outcomes:- Knowledge about the antimicrobial activity and efficacy of their novel surfaces.- Identify the best material combinations for incorporation into infection control products.- Efficacy of material release mechanisms: stochastic/natural, triggered and directed.- Prototype deployment.- Paper publication.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
基于spA-Gel负载Anti-HMGB1原位靶向免疫耐受的猪胰岛类器官移植研
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:程瑶
-
依托单位:
TKIs氘代化修饰通过促进HCC铁死亡增强免疫原性并增敏anti-PD-1治疗的机制研究
-
批准号:JCZRQN202500319
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
肺癌外周血淋巴细胞亚群预测anti-PD1/PDL1疗效的鉴定及应用研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:仇凤启
-
依托单位:
构建α-突触核蛋白特异性CAR-Treg治疗抗NMDAR脑炎的研究
-
批准号:2025JJ80620
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘钰
-
依托单位:
Anti-MDA5阳性皮肌炎病人的NK细胞数量与功能改变在间质性肺疾病中的作用与机制研究
-
批准号:MS25H100014
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:韩咏梅
-
依托单位:
CCL2介导PGK1的O-GlcNAc糖基化修饰诱导CAFs代谢重编程促进头颈癌anti-PD-1免疫治疗耐药的机制研究
-
批准号:
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:苑振楠
-
依托单位:
特发性膜性肾病血清标志物anti-PLA2R-IgG4检测方法的建立及临床应用
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:徐燕
-
依托单位:
经 anti-GPC3 修饰的外泌体靶向递送索拉非尼与放疗联合诱
导肝细胞癌铁死亡的研究
-
批准号:2024JJ9608
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:段和新
-
依托单位:
千金藤素通过自噬损伤导致的免疫原性细胞死亡促进 anti-PD1 治疗MSS 型结直肠癌的疗效与机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2024
-
负责人:赵明
-
依托单位:
周细胞 ZEB1/SPP1 旁分泌轴招募 MDSCs 诱导
卵巢癌 anti-PD1/PD-L1 疗法耐药的机制研究
-
批准号:Y24H310009
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:程溥
-
依托单位: